Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick(Fred Hutch Cancer Center)

Journal of Clinical Investigation

August 13, 2019

10.1172/jci126091

Cited by 138

Related Papers

No related papers found

Powered by citation graph analysis